Primary Recipient

DANA-FARBER CANCER INSTITUTE, INC.

Amount

$2,228,805.00

Award Date

9/28/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The goal of the proposed work is the development of novel approaches to the stimulation of fetal hemoglobin (HbF) production in red blood cells of adults. HbF is a known modifier of the severity of the major hemoglobin disorders, sickle cell anemia and be

Recipients Connected to Award

Recipient	Role	Amount
DANA-FARBER CANCER INSTITUTE, INC.	Primary recipient	$1,581,895.00
MASSACHUSETTS GENERAL HOSPITAL, THE	Sub-recipient	$318,616.00
UNIVERSITY OF CALIFORNIA, LOS ANGELES	Sub-recipient	$226,410.00
CHILDREN'S HOSPITAL CORPORATION, THE	Sub-recipient	$101,884.00

Vendors Connected to Award

Vendor	Role	Amount
The Broad Institute, Inc.	Primary vendor	$52,025.00
Applied Biosystems	Primary vendor	$39,479.71
Stem Cell Technologies, Inc.	Primary vendor	$47,350.00
Qiagen	Primary vendor	$53,347.69